Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The knowns and unknowns of SSRI treatment in young people with depression and anxiety: efficacy, predictors, and mechanisms of action
Susannah E. Murphy, Liliana Capitão, Sophie Giles, et al.
The Lancet Psychiatry (2021) Vol. 8, Iss. 9, pp. 824-835
Open Access | Times Cited: 64

Showing 26-50 of 64 citing articles:

Young people’s mental health is finally getting the attention it needs

Nature (2021) Vol. 598, Iss. 7880, pp. 235-236
Open Access | Times Cited: 14
Omega-3 supplements in the prevention and treatment of youth depression and anxiety symptoms: A scoping review
Natalie M. Reily, Samantha Tang, Ashlee Negrone, et al.
PLoS ONE (2023) Vol. 18, Iss. 4, pp. e0284057-e0284057
Open Access | Times Cited: 5
Fluoxetine exposure throughout neurodevelopment differentially influences basilar dendritic morphology in the motor and prefrontal cortices
Susan E. Maloney, Dora R. Tabachnick, Christine Jakes, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 8
Effects of Selective Serotonin Reuptake Inhibitor Treatment on Ovarian Reserves in Patients with Depression
Soner Gök, Berfin GÖK, Erkan Alataş, et al.
Medicina (2023) Vol. 59, Iss. 3, pp. 517-517
Open Access | Times Cited: 4
Anxiety disorders in general medical practice – clinical picture, diagnosis, optimized approaches to therapy
D. S. Petelin, O. Yu. Sorokina, D. V. Troshina, et al.
Meditsinskiy sovet = Medical Council (2023), Iss. 3, pp. 110-118
Open Access | Times Cited: 4
Depression among Patients with an Implanted Left Ventricular Assist Device: Uncovering Pathophysiological Mechanisms and Implications for Patient Care
Hilmi Alnsasra, Fouad Khalil, Radha Kanneganti Perue, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11270-11270
Open Access | Times Cited: 4
Zymosan A produces a rapid and sustained antidepressant effect in chronically stressed mice by stimulating hippocampal microglia
Tao Zhu, Bingran Chen, Han Han, et al.
Behavioural Pharmacology (2023) Vol. 34, Iss. 6, pp. 318-329
Closed Access | Times Cited: 4
Role of 5-hydroxytryptamine type 3 receptors in the regulation of anxiety reactions
Yinan Du, Zhiwei Li, Yukui Zhao, et al.
Journal of Zhejiang University SCIENCE B (2024) Vol. 25, Iss. 1, pp. 23-37
Open Access | Times Cited: 1
Subjective experience of the environment determines serotoninergic antidepressant treatment outcome in male mice
S. Poggini, G. Matte Bon, N. Ciano Albanese, et al.
Journal of Affective Disorders (2024) Vol. 350, pp. 900-908
Closed Access | Times Cited: 1
A scoping review of functional near-infrared spectroscopy biomarkers in late-life depression: Depressive symptoms, cognitive functioning, and social functioning
Yujie Tong, Qiwei Wang, Xiao Wang, et al.
Psychiatry Research Neuroimaging (2024) Vol. 341, pp. 111810-111810
Closed Access | Times Cited: 1
SSRI antidepressant citalopram reverses the Warburg effect to inhibit hepatocellular carcinoma by directly targeting GLUT1
Fangyuan Dong, Kang He, Shan Zhang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access | Times Cited: 1
A Bibliometric Analysis of the WoSCC Literature on the Use of Selective Serotonin Reuptake Inhibitors as Antidepressants
Jiyang Li, Xinxing Fei, Shiqi Wang, et al.
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 4961-4974
Open Access | Times Cited: 1
5-Hydroxytryptophan artificial synaptic vesicles across the blood-brain barrier for the rapid-acting treatment of depressive disorder
Chang Peng, Jingwen Ma, Ke Li, et al.
Materials Today Bio (2024) Vol. 29, pp. 101357-101357
Open Access | Times Cited: 1
Acute neural effects of fluoxetine on emotional regulation in depressed adolescents
Liliana Capitão, Robert Chapman, Nicola Filippini, et al.
Psychological Medicine (2022) Vol. 53, Iss. 10, pp. 4799-4810
Open Access | Times Cited: 6
Imidazoles as Serotonin Receptor Modulators for Treatment of Depression: Structural Insights and Structure–Activity Relationship Studies
Kapil Kumar Goel, Somesh Thapliyal, Rajeev Kharb, et al.
Pharmaceutics (2023) Vol. 15, Iss. 9, pp. 2208-2208
Open Access | Times Cited: 3
Is combined antidepressant medication (ADM) and psychotherapy better than either monotherapy at preventing suicide attempts and other psychiatric serious adverse events for depressed patients? A rare events meta-analysis
Nur Hani Zainal
Psychological Medicine (2023) Vol. 54, Iss. 3, pp. 457-472
Open Access | Times Cited: 3
One Day Away from Mum has Lifelong Consequences on Brain and Behaviour
Natália Ferreira de Sá, Rosana Camarini, Deborah Suchecki
Neuroscience (2023) Vol. 525, pp. 51-66
Open Access | Times Cited: 2
Are antidepressants effective in the treatment of depression in the elderly? A critical umbrella review on reviews, methods, and future perspectives
Michael Falk Hvidberg
Mental Health Science (2023) Vol. 1, Iss. 2, pp. 85-103
Open Access | Times Cited: 2
Treatment guesses in the Treatment for Adolescents with Depression Study: Accuracy, unblinding and influence on outcomes
Jon Jureidini, Joanna Moncrieff, Julie Klau, et al.
Australian & New Zealand Journal of Psychiatry (2023) Vol. 58, Iss. 4, pp. 355-364
Open Access | Times Cited: 2
Effects of adjunctive brexpiprazole on sleep-wake and circadian parameters in youth with depressive disorders: study protocol for a clinical trial
Joanne S. Carpenter, Natalia Zmicerevska, Jacob J. Crouse, et al.
BMJ Open (2022) Vol. 12, Iss. 9, pp. e056298-e056298
Open Access | Times Cited: 3
In vitro effects of selective serotonin reuptake inhibitors on Cryptococcus gattii capsule and biofilm
Letícia Rampazzo da Gama Viveiro, Amanda Rodrigues Rehem, Evelyn Luzia de Souza Santos, et al.
Pathogens and Disease (2024) Vol. 82
Open Access
Active Compounds of Red Ginger as Antioxidant Activity in the Supplementation and Treatment of Depression
Ira Aini Dania, Rusdiana Rusdiana, Aldy Safruddin Rambe, et al.
Qubahan Academic Journal (2024) Vol. 4, Iss. 1, pp. 177-184
Open Access
Persistent negative symptoms in young people at clinical high risk of psychosis treated with an Italian early intervention program: a longitudinal study
C. Ricci, Emanuela Leuci, Emanuela Quattrone, et al.
European Archives of Psychiatry and Clinical Neuroscience (2024) Vol. 274, Iss. 6, pp. 1311-1326
Open Access
The Effect of Selective Serotonin Reuptake Inhibitors on Impulsivity in Young Adults with Major Depression in the Early Phase of Treatment
Çağrı Öğüt, Çağrı Çimentepe Sezer
Turkish Journal of Psychiatry (2024)
Open Access
Machine Learning Models to Classify and Predict Depression in College Students
Orlando Iparraguirre-Villanueva, Cleoge Paulino-Moreno, Andrés Epifanía-Huerta, et al.
International Journal of Interactive Mobile Technologies (iJIM) (2024) Vol. 18, Iss. 14, pp. 148-163
Open Access

Scroll to top